Ligand id: 7594

Name: dihydrocodeine

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: dihydrocodeine

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 2
Hydrogen bond donors 1
Rotatable bonds 1
Topological polar surface area 41.93
Molecular weight 301.17
XLogP 1.57
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Used to treat pain or severe dyspnea (shortness of breath), or as an antitussive, either alone or as a brand mixture with paracetamol e.g. co-dydramol, or aspirin. There is no information of the US FDA website regarding approval of a single agent formulation containing dihydrocodeine. Individual national approval agencies may have granted marketing authorisation for this drug (e.g. UK 1986).
Mechanism Of Action and Pharmacodynamic Effects
Dihydrocodeine is a μ opioid receptor agonist. Activation of this receptor on central nervous system neurons inhibits intracellular adenylate cyclase. Downstream this leads to reduced calcium influx via membrane calcium channels, and increased potassium permeability by opening membrane potassium channels. This ultimately leads to hyperpolarization of the cell membrane potential and suppression of action potential transmission of ascending pain pathways.